ResMed | RMD - 销售成本

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 33.2B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	销售成本	更改		日
Ansell	USD 605.3M		351.2M	2025-12
Artivion	USD 42.85M		3.86M	2025-12
AtriCure	USD 34.98M		3.04M	2026-06
Baxter International	USD 1.93B		118M	2026-06
Cochlear	AUD 319.2M		160.35M	2025-12
Cooper Companies	USD 393.8M		17M	2026-03
CSL	USD 3.87B		2.08B	2025-12
Dexcom	USD 478.4M		36.8M	2026-06
Edwards Lifesciences	USD 392.4M		29.8M	2026-06
Fisher Paykel Healthcare	NZD 435.5M		32.7M	2026-06
Globus Medical	USD 271M		7.41M	2026-06
Haemonetics	USD 136.58M		11.56M	2026-06
Idexx Laboratories	USD 437.5M		19.42M	2026-06
Inogen	USD 39.59M		1.27M	2024-09
Insulet	USD 239.1M		6.4M	2026-06
Integra LifeSciences	USD 188.86M		10.15M	2026-06
Intuitive Surgical	USD 931.9M		8.4M	2026-06
Medtronic	USD 3.8B		195M	2026-03
Philips	EUR 2.21B		70M	2026-06
Ramsay Health Care	AUD 3.05B		78.7M	2025-12
ResMed	USD 612.93M		61.26M	2026-06
Sigma Healthcare	AUD 1.55B		165.16M	2024-12
Sonic Healthcare	AUD 751.66M		801.13M	2024-12
Steris	USD 808.6M		82.7M	2026-06
Teleflex	USD 238.62M		2.21M	2026-06
Thermo Fisher Scientific	USD 7.54B		577M	2026-06